UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011140
Receipt number R000013045
Scientific Title Evaluation of safety and efficacy for endoscopic biopsy using thin forceps
Date of disclosure of the study information 2013/07/08
Last modified on 2018/01/09 10:53:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of safety and efficacy for endoscopic biopsy using thin forceps

Acronym

Safety and efficacy of thin forceps

Scientific Title

Evaluation of safety and efficacy for endoscopic biopsy using thin forceps

Scientific Title:Acronym

Safety and efficacy of thin forceps

Region

Japan


Condition

Condition

Neoplasms in upper GI tract

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of efficacy of thin biopsy forceps compared to normal biopsy forceps

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Rate of specimens which can be evaluated appropriately.

Key secondary outcomes

Endoscopic bleeding time.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Endoscopic biopsy using thin forceps normal forceps

Interventions/Control_2

Endoscopic biopsy using normal forceps

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(A)Scheduled endoscopic treatment of neoplasms in stomach or esophagus.
(B)Neoplasm gross type is 0-IIa/IIb/IIc.
(C)Demarcation line is detectable.
(D)Informed consent.
(E)Performance status(ECOG):0-2.

Key exclusion criteria

(A)Severe hematological, hepatological, or renal disorder accompanied with hemorrhagic tendency.
(B)Other severe comorbidities.
(C)During anticancer chemotherapy.
(D)Poor compliance.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoshi Ono

Organization

The University of Tokyo Hospital

Division name

Department of Gastroenterology

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo.

TEL

03-3815-5411

Email

satoshi-tky@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Satoshi Ono

Organization

The University of Tokyo Hospital

Division name

Department of Gastroenterology

Zip code


Address

7-3-1, Hongo, BUnkyo-ku, Tokyo.

TEL

03-3815-5411

Homepage URL


Email

satoshi-tky@umin.ac.jp


Sponsor or person

Institute

Department of Gastroenterology, the University of Tokyo Hospital.

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 07 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 03 Month 08 Day

Date of IRB


Anticipated trial start date

2013 Year 07 Month 08 Day

Last follow-up date

2014 Year 07 Month 31 Day

Date of closure to data entry

2014 Year 07 Month 31 Day

Date trial data considered complete

2014 Year 08 Month 31 Day

Date analysis concluded

2014 Year 10 Month 30 Day


Other

Other related information



Management information

Registered date

2013 Year 07 Month 07 Day

Last modified on

2018 Year 01 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013045


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name